US Patent

US7955619 — Abuse resistant drugs, method of use and method of making

Formulation · Assigned to Inspirion Delivery Technologies LLC · Expires 2028-08-12 · 2y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an abuse-resistant oral pharmaceutical composition that includes a barrier layer and a diffusion layer with a drug that diffuses within the gastrointestinal tract.

USPTO Abstract

An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprises a drug that is substantially homogeneously distributed within the second polymer and diffuses from the diffusion layer within the gastrointestinal (GI) tract; and optionally an expansion layer comprising an expandable polymer, wherein the expansion layer is substantially covered by the barrier layer. Methods of making the same and methods of using the same are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
US7955619
Jurisdiction
US
Classification
Formulation
Expires
2028-08-12
Drug substance claim
No
Drug product claim
Yes
Assignee
Inspirion Delivery Technologies LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.